WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.82 Billion CNY | 1.55% |
| 2022 | 6.72 Billion CNY | 39.25% |
| 2021 | 4.82 Billion CNY | 90.64% |
| 2020 | 2.53 Billion CNY | 52.71% |
| 2019 | 1.65 Billion CNY | 62.98% |
| 2018 | 1.01 Billion CNY | 54.08% |
| 2017 | 660.55 Million CNY | 69.76% |
| 2016 | 389.11 Million CNY | 115.31% |
| 2015 | 180.72 Million CNY | 46.62% |
| 2014 | 123.25 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 3.34 Billion CNY | 0.0% |
| 2023 Q4 | 3.26 Billion CNY | 0.0% |
| 2023 FY | 6.82 Billion CNY | 1.55% |
| 2023 Q2 | 3.56 Billion CNY | 0.0% |
| 2022 FY | 6.72 Billion CNY | 39.25% |
| 2022 Q2 | 3.41 Billion CNY | 0.0% |
| 2022 Q4 | 3.31 Billion CNY | 0.0% |
| 2021 Q4 | 2.53 Billion CNY | 0.0% |
| 2021 Q2 | 2.29 Billion CNY | 0.0% |
| 2021 FY | 4.82 Billion CNY | 90.64% |
| 2020 Q2 | 782.35 Million CNY | 0.0% |
| 2020 FY | 2.53 Billion CNY | 52.71% |
| 2020 Q4 | 1.75 Billion CNY | 0.0% |
| 2019 FY | 1.65 Billion CNY | 62.98% |
| 2019 Q4 | 987.69 Million CNY | 0.0% |
| 2019 Q2 | 671.01 Million CNY | 0.0% |
| 2018 FY | 1.01 Billion CNY | 54.08% |
| 2018 Q4 | 603.04 Million CNY | 0.0% |
| 2018 Q2 | 414.71 Million CNY | 0.0% |
| 2017 FY | 660.55 Million CNY | 69.76% |
| 2017 Q2 | 264.26 Million CNY | 0.0% |
| 2017 Q4 | 396.28 Million CNY | 0.0% |
| 2016 Q2 | 186.62 Million CNY | 0.0% |
| 2016 Q4 | 202.48 Million CNY | 0.0% |
| 2016 FY | 389.11 Million CNY | 115.31% |
| 2015 Q4 | 45.18 Million CNY | 0.0% |
| 2015 FY | 180.72 Million CNY | 46.62% |
| 2015 Q1 | 45.18 Million CNY | 46.62% |
| 2015 Q2 | 45.18 Million CNY | 0.0% |
| 2015 Q3 | 45.18 Million CNY | 0.0% |
| 2014 Q3 | 30.81 Million CNY | 0.0% |
| 2014 Q1 | 30.81 Million CNY | 0.0% |
| 2014 FY | 123.25 Million CNY | 0.0% |
| 2014 Q4 | 30.81 Million CNY | 0.0% |
| 2014 Q2 | 30.81 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -45422.375% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -220112762.669% |
| SQZ Biotechnologies Company | 9.79 Million USD | -69615.142% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -58228.216% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -5632.55% |
| Mesoblast Limited | -35.16 Million USD | 19515.096% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 19993953.587% |
| Genus plc | 178.7 Million USD | -3720.874% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -1664571.778% |
| Marizyme, Inc. | 457.7 Thousand USD | -1491678.712% |
| ContraFect Corporation | -154 Thousand USD | 4433801.948% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 62071927.273% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 13655902.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -8894913.093% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -10388016.176% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 1762134.421% |
| MultiCell Technologies, Inc. | 49.32 USD | -13844081408.516% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -16857.41% |
| EV Biologics, Inc. | 48.9 Thousand USD | -13962887.73% |
| Q BioMed Inc. | -8988.00 USD | 75966955.808% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -24065.284% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 44268130.342% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | -3002.125% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -9754044.286% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 5495348.328% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -10972646.119% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 137881784.168% |
| Arch Therapeutics, Inc. | -2439.00 USD | 279946840.467% |
| IMV Inc. | -962.29 Thousand USD | 709641.223% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -4859616.014% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 7001998.17% |
| GB Sciences, Inc. | -624.00 USD | 1094215003.846% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 7936935.681% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 9.696% |
| Halberd Corporation | -208.00 USD | 3282644811.538% |
| Enzolytics Inc. | 30.7 Thousand USD | -22234825.752% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -503008.442% |
| SYBLEU INC | 11.69 Thousand USD | -58377986.525% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -1415205.545% |
| argenx SE | 1.1 Billion USD | -515.969% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 26566.784% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -1105840.711% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | -1567.159% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 77099253.117% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -15292.781% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 598213.917% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -690996.387% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -70942.566% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 8143191.748% |
| BioStem Technologies, Inc. | 15.42 Million USD | -44165.6% |
| ONE Bio Corp. | 20.12 Million USD | -33826.715% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 57692546.134% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 14148551.066% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -3867084.527% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -3867084.527% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 1327168.667% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 1083656.459% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 23544586.207% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -1517066.36% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 2137111.396% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -148074.935% |
| Bioxytran, Inc. | -8285.00 USD | 82412906.276% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 1830636.461% |
| Neutra Corp. | 14.33 Thousand USD | -47630880.119% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 8326808.537% |
| PureTech Health plc | -1.6 Million USD | 426045.165% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 682047.213% |
| IXICO plc | 3.27 Million USD | -208704.312% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 983947.406% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 381334.003% |
| CSL Limited | 7.7 Billion USD | 11.384% |
| Cellectis S.A. | 18 Thousand USD | -37932683.333% |